Literature DB >> 19846414

Choroidal filling delay in choroidal neovascularisation due to pathological myopia.

Taku Wakabayashi1, Yasushi Ikuno.   

Abstract

AIM To assess the choroidal thickness and choroidal circulatory changes in eyes with myopic choroidal neovascularisation (mCNV). METHODS Retrospective, consecutive, observational case series. Forty-two consecutive eyes (17 eyes with newly diagnosed mCNV and 25 eyes without CNV) were included. Choroidal circulation was evaluated by indocyanine green angiography (ICGA), and choroidal thickness was measured by spectral-domain optical coherence tomography (SD-OCT). The factors associated with mCNV were evaluated. RESULTS Sixteen (94%) of 17 eyes with mCNV and six (24%) of 25 eyes without mCNV had well-defined hypofluorescence at the macular region on arterial phase ICGA, that is, a choroidal filling delay. Older age (p<0.001), the presence of a choroidal filling delay (p<0.001) and reduced choroidal thickness (p=0.003) were significantly associated with mCNV on univariate analysis. The most important of these three factors associated with mCNV, in order of importance, were the choroidal filling delay (OR=41.5, p<0.001) and choroidal thickness (per 1 microm, OR=0.97, p=0.01). Older age was significantly associated with both choroidal filling delay (per 1 year, OR=1.16, p<0.001) and choroidal thinning (regression coefficient=-1.22, p<0.001). CONCLUSIONS Significant choroidal changes were observed in eyes with mCNV. Ischaemia-induced growth factor expression caused by decreased choroidal perfusion may be related to the development of mCNV.

Entities:  

Mesh:

Year:  2009        PMID: 19846414     DOI: 10.1136/bjo.2009.163535

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  22 in total

1.  Choroidal neovascularization secondary to pathological myopia-macular Bruch membrane defects as prognostic factor to anti-VEGF treatment.

Authors:  João Coelho; André Ferreira; Ana Carolina Abreu; Sílvia Monteiro; Maria João Furtado; Miguel Gomes; Miguel Lume
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-03-21       Impact factor: 3.117

2.  Factors associated with macular complications in highly myopic eyes with dome-shaped macular configuration.

Authors:  Mumin Hocaoglu; M Giray Ersoz; Isil Sayman Muslubas; Serra Arf; Murat Karacorlu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-04       Impact factor: 3.117

3.  Corneal morphology correlates with choriocapillaris perfusion in myopic children.

Authors:  Xuewei Li; Lu Ma; Jie Hu; Qiong Xu; Kai Wang; Yan Li; Jia Qu; Mingwei Zhao
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-04-30       Impact factor: 3.535

Review 4.  Management of Myopic Choroidal Neovascularization: Focus on Anti-VEGF Therapy.

Authors:  Kelvin Yi Chong Teo; Wei Yan Ng; Shu Yen Lee; Chui Ming Gemmy Cheung
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

5.  Choroidal thickness in retinal pigment epithelial tear as measured by spectral domain optical coherence tomography.

Authors:  Kavita V Bhavsar; Lauren Branchini; Heeral Shah; Caio V Regatieri; Jay S Duker
Journal:  Retina       Date:  2014-01       Impact factor: 4.256

6.  Scleral thickness in highly myopic eyes measured by enhanced depth imaging optical coherence tomography.

Authors:  M Hayashi; Y Ito; A Takahashi; K Kawano; H Terasaki
Journal:  Eye (Lond)       Date:  2013-01-11       Impact factor: 3.775

Review 7.  Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application.

Authors:  Yan Zhang; Qian Han; Yusha Ru; Qiyu Bo; Rui Hua Wei
Journal:  Drug Des Devel Ther       Date:  2015-07-02       Impact factor: 4.162

8.  What ocular and systemic variables affect choroidal circulation in healthy eyes.

Authors:  Takeshi Iwase; Kentaro Yamamoto; Misato Kobayashi; Eimei Ra; Kenta Murotani; Hiroko Terasaki
Journal:  Medicine (Baltimore)       Date:  2016-10       Impact factor: 1.889

9.  Aqueous Concentrations of Vascular Endothelial Growth Factor in Eyes with High Myopia with and without Choroidal Neovascularization.

Authors:  Taku Wakabayashi; Yasushi Ikuno; Yusuke Oshima; Toshimitsu Hamasaki; Kohji Nishida
Journal:  J Ophthalmol       Date:  2013-03-06       Impact factor: 1.909

Review 10.  Myopic choroidal neovascularisation: current concepts and update on clinical management.

Authors:  Tien Y Wong; Kyoko Ohno-Matsui; Nicolas Leveziel; Frank G Holz; Timothy Y Lai; Hyeong Gon Yu; Paolo Lanzetta; Youxin Chen; Adnan Tufail
Journal:  Br J Ophthalmol       Date:  2014-07-01       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.